Genprex, Inc.
(NASDAQ : GNPX)

( )
GNPX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
MRKMerck & Co., Inc.
2.18%76.360.6%$921.58m
BMYBristol-Myers Squibb Company
2.29%45.641.4%$898.26m
PFEPfizer Inc.
0.64%39.620.9%$826.97m
JNJJohnson & Johnson
0.32%139.650.7%$822.68m
LLYEli Lilly and Company
0.19%118.221.0%$646.39m
ABBVAbbVie, Inc.
0.84%79.332.2%$442.79m
NVSNovartis AG Sponsored ADR
3.59%80.610.2%$306.24m
AZNAstraZeneca PLC Sponsored ADR
0.85%39.051.3%$259.49m
GSKGlaxoSmithKline plc Sponsored ADR
0.75%40.230.2%$103.67m
NVONovo Nordisk A/S Sponsored ADR Class B
0.12%48.430.1%$66.35m
SNYSanofi Sponsored ADR
-0.65%41.210.2%$37.98m
LCILannett Company, Inc.
-0.63%7.1536.7%$7.23m
AKTXAkari Therapeutics Plc Sponsored ADR
0.25%4.011.6%$6.00m
EPIXESSA Pharma Inc
-1.58%2.290.1%$0.03m

Company Profile

Genprex, Inc. is a clinical stage gene therapy company, which engages in the development of novel proprietary technology platform for the treatment of cancer. It develops the Oncoprex immunogene therapy which targets the non-small cell lung cancer and other solid tumors. The company was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.